Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis

Cited by (351)

Items 201–300 of 351

1. Dopaminergic signaling in prefrontal cortex contributes to the antidepressant effect of electroacupuncture: An iTRAQ‐based proteomics analysis in a rat model of CUMS
   Jialing Zhang, Jiping Zhang, Zhinan Zhang, Yu Zheng, Zhong Zheng, Zengyu Yao, Xiaowen Cai, Lixing Lao, Yong Huang, Shanshan Qu · 2021 · The Anatomical Record
2. Expectation focused and frequency enhanced cognitive behavioural therapy for patients with major depression (EFFECT): a study protocol of a randomised active-control trial
   Anne-Catherine I. Ewen, Gaby Michaela Bleichhardt, Winfried Rief, Pia von Blanckenburg, Katrin Wambach, Marcel Wilhelm · 2023 · BMJ Open
3. Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?
   Jon N Jureidini, Barbara J. Mintzes, Melissa K Raven · 2008 · PharmacoEconomics
4. Ishige foliacea ameliorates depressive-like behaviors in stress hormone treated mice
   Minji Kim, Sang‐Oh Kwon, Sueongmok Cho, Min Young Um · 2022 · Applied Biological Chemistry
5. Effectiveness of cognitive behavioral therapy and fluoxetine on sexual function of women with obsessive compulsive disorder: A double-blind randomized controlled trial
   Zahra Sabetnejad, Fatemeh Assarian, Abdollah Omidi, Mohammad Reza Najarzadegan · 2016 · Electronic physician
6. Association between depression, antidepressant use, and the incidence of atherosclerotic cardiovascular diseases
   Hyewon Kim, You‐Bin Lee, Jungkuk Lee, Dongwoo Kang, Gyuri Kim, Sang‐Man Jin, Jae Hyeon Kim, Kyu Yeon Hur, Hong Jin Jeon · 2024 · Journal of Affective Disorders
7. Explaining the variation between practices in the duration of new antidepressant treatment: a database cohort study in primary care.
   C. Burton, Isobel M. Cameron, N. Anderson · 2015 · The British journal of general practice : the journal of the Royal College of General Practitioners
8. Protective effects of curcumin on desipramine-induced islet β-cell damage via AKAP150/PKA/PP2B complex
   Min Hu, Jiaying Cai, Yao He, Kui Chen, Hao Feng, Jinsen Kang, Yan Pan, Lu Tie, Xue-jun Li · 2023 · Acta Pharmacologica Sinica
9. Johanniskrautextrakte bei Depression – Entwicklung eines Cochrane Reviews von 1993 bis 2008
   Klaus Linde · 2008 · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen
10. Sociodemographic and clinical factors associated with antidepressant type in a national sample of the home health care elderly
    Judith D. Weissman, Barnett S. Meyers, Samiran Ghosh, MARTHA LIVINGSTON BRUCE · 2011 · General Hospital Psychiatry
11. Inhibition of Efavirenz Metabolism by Sertraline and Nortriptyline and Their Effect on Efavirenz Plasma Concentrations
    Virginia Melis, Iris Usach, Patricia Gandía, José‐Esteban Peris · 2015 · Antimicrobial Agents and Chemotherapy
12. Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
    Gerald Gartlehner, Richard A. Hansen, Laura C Morgan, Kylie J. Thaler, Linda J Lux, Megan Van Noord, Ursula Mager, Bradley Neil Gaynes, Patricia Thieda, Michaela Strobelberger et al. · 2011
13. Nursing Challenges in the Administration of Oral Antidepressant Medications in Gastric Bypass Patients
    Meg Voelker, Terri G. Foster · 2007 · Journal of PeriAnesthesia Nursing
14. Mental health in the care of paramedics: part 1
    Chris J. Hawley, Ankush Singhal, Ag Roberts, Heather Atkinson, Caroline Whelan · 2011 · Journal of Paramedic Practice
15. Use of electroacupuncture to accelerate the antidepressant action of selective serotonin reuptake inhibitors: a single-blind, randomised, controlled study.
    Z J Zhang, Roger Ng, Sui‐Cheung Man, J T Y Li, Wendy Wong, H K Wong, D Wang, M.-T. Wong, A.W.K. Tsang, Ka Chee Yip et al. · 2013 · PubMed
16. Cost-Effectiveness Analysis of Complementary and Alternative Medicine in Treating Anxiety Disorders
    Matthew Kutch · 2016 · Alternative & Integrative Medicine
17. Treatment-Resistant Depression
    Cristina Cusin, Stefan Peyda · 2018 · Springer eBooks
18. Pharmacological Treatment of Major Depressive Disorder
    Joshua Daniel Rosenblat, Roger S. McIntyre · 2019 · Elsevier eBooks
19. Outcomes reported in randomised clinical trials of major depressive disorder treatments in adolescents: a systematic scoping review protocol
    Andrea Monsour, Emma J. Mew, Péter Szatmári, Sagar R. Patel, Leena Saeed, Martin Offringa, Nancy J. Butcher · 2019 · BMJ Open
20. fMRI neurofeedback for disorders of emotion regulation
    Kymberly D. Young, Naomi B. Fine, T. Hendler · 2021 · fMRI Neurofeedback
21. Alternatives and Adjuncts to Opioids for the Treatment of Chronic Pain
    Patrick J. Laguerre · 2013 · North Carolina Medical Journal
22. The optometrist’s role in the management of clinical depressive disorders
    Steven H. Schwartz · 2007 · Optometry
23. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2016 · Springer eBooks
24. Why do antidepressant therapies have such a poor success rate?
    Christoph Hiemke · 2016 · Expert Review of Neurotherapeutics
25. Fluvoxamine versus other anti-depressive agents for depression
    Ichiro M Omori, Norio Watanabe, Atsuo Nakagawa, Andrea Cipriani, Corrado Barbui, Hugh McGuire, Rachel C. Churchill, Toshi A. Furukawa, Meta-Analysis of New Generation Ant · 2006 · Cochrane Database of Systematic Reviews
26. Pharmacokinetic Interaction between Nevirapine and Nortriptyline in Rats: Inhibition of Nevirapine Metabolism by Nortriptyline
    Iris Usach, Virginia Melis, Patricia Gandía, José‐Esteban Peris · 2014 · Antimicrobial Agents and Chemotherapy
27. Psychopharmaka
    Martin J. Lohse, Johanna Seifert, Stefan Bleich · 2021 · Springer eBooks
28. Serotonin Dysfunction in Autism
    Mary E. Blue, Michael V. Johnston, Carolyn B. Moloney, Christine F. Höhmann · 2008 · Humana Press eBooks
29. COMPARISONS BETWEEN PSYCHOTROPIC DRUGS: MUST THE RISK OF SIDE EFFECTS DICTATE OUR PRACTICES?
    Nicolas Zdanowicz, D. Jacques, Christine Reynaert · 2008 · Acta Clinica Belgica
30. A different way of looking at depression
    Evelyn M. van Weel-Baumgarten, Peter LBJ Lucassen, Lieke Hassink-Franke, Henk Schers · 2010 · International Journal of Clinical Practice
31. Neuromuscular blocking effect of fluoxetine and its interaction with rocuronium
    Jayshree C. Patel, Manish Jasmatbhai Barvaliya, Tejas Kamleshbhai Patel, Chandrabhanu B. Tripathi · 2013 · Autonomic and Autacoid Pharmacology
32. Mood Disorders and Bariatric Surgery Patients: Pre- and Post- Surgery Clinical Course- An Overview
    Lucia Godini · 2016 · Journal of Obesity and Weight-loss Medication
33. Managing depression in primary care: it's not only what you do it's the way that you do it
    Jed Boardman, Paul Walters · 2009 · British Journal of General Practice
34. Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study
    Surya Sridharan, Simon Erridge, Carl Holvey, Ross Coomber, Wendy Holden, James Rucker, Michael W. Platt, Mikael Hans Sodergren · 2024 · Journal of Pain & Palliative Care Pharmacotherapy
35. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2010 · Springer eBooks
36. Early life stress and the role of environmental and molecular moderators in the ontology of pathological and resilient behavioral phenotypes
    Nicholas J. Collins, Taylor S. Campbell, Katelyn M. Donoghue, Urmi Ghosh, Jessica N. Smith, Maeve C. O’Shea, Christina M. Nelson, Olivia K. Bigham, Tania L. Roth · 2023 · Molecular Psychology Brain Behavior and Society
37. Opinion: Direct-To-Consumer Advertising of Prescription Medicines: A Counter Argument
    Barbara J. Mintzes, Dee A. Mangin · 2009 · Future Medicinal Chemistry
38. Pharmacogenetic Testing in Schizophrenia and Posttraumatic Stress Disorder
    Bronwyn Ramey-Hartung, Rifaat S. El-Mallakh, Kristen K. Reynolds · 2008 · Clinics in Laboratory Medicine
39. Characteristics Associated With Purchasing Antidepressant or Antianxiety Medications Through Primary Care in Israel
    Liat Ayalon, Revital Gross, Aviv Yaari, Elan Feldhamer, Ran D. Balicer, Margalit Goldfracht · 2011 · Psychiatric Services
40. Unipolare Depression – Pharmakotherapie und Psychotherapie (ICD-10 F3)
    Max Schmauß, Elisabeth Schramm, Thomas Berger · 2009 · Elsevier eBooks
41. Economic evaluation of desvenlafaxine in the treatment of major depressive disorder in Spain
    Javier Rejas Gutiérrez, Milagrosa Blanca Tamayo, Josep Gascón Barrachina, Beatriz Armada Peláez · 2016 · Revista de Psiquiatría y Salud Mental (English Edition)
42. Reboxetine versus other antidepressive agents for depression
    Rachel C. Churchill, Deborah M Caldwell, Hugh McGuire, Corrado Barbui, Andrea Cipriani, Toshi A. Furukawa, Norio Watanabe, Glyn Lewis · 2009 · Cochrane Database of Systematic Reviews · Retracted
43. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2011 · Springer eBooks
44. Psychopharmaka
    Martin J. Lohse · 2020 · Springer eBooks
45. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2019 · Springer eBooks
46. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2018 · Springer eBooks
47. Depression and anxiety outcomes at a free clinic in a rural state
    Mary E. Burman, Jennifer L. Petrie · 2008 · Journal of the American Academy of Nurse Practitioners
48. Diagnosis and Treatment of Major Depression 2007
    deSa Patricia, David Wm. Price · 2007 · The Permanente Journal
49. Antidepressants as Analgesics
    Howard S. Smith, Charles E. Argoff, Gary J. McCleane · 2013 · Elsevier eBooks
50. The Late-Life Depression a Comprehensive Review of Clinical, Pathophysiological, and Therapeutic Considerations
    Thomas Fraccalini, Beatrice TAROZZO, Thomas Roberts, Andrea Trogolo, Grazia Ceravolo, Alessandro Maraschi, Julia Michelin Vecchini, Laura Santos Ribeiro, Valerio Piras, Elisa Binello et al. · 2026 · Journal of Geriatric Psychiatry and Neurology
51. Staying in my lane: An exploration of counsellors' and psychotherapists' understanding and use of nutrition in the therapy room
    Jayne Leonard · 2023 · Counselling and Psychotherapy Research
52. Acupuncture effects on emotional reactivity of youth with self-reported depressive symptoms
    Qian Wu, Dehui Lin, Xiuyun Wen, Shanze Wang, Derek J. Fisher, Wenbin Fu, Jiajin Yuan · 2025 · Psychoradiology
53. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2015 · Springer eBooks
54. Acupuncture for Depression: The Mechanism Underlying Its Therapeutic Effect
    Muthmainah Muthmainah, Ida Nurwati · 2016 · Medical Acupuncture
55. THE ROLES OF NEUROTRANSMITTERS, HORMONES AND BRAIN-DERIVED NEUROTROPHIC FACTORS IN THE PATHOGENESIS OF DEPRESSION
    Sirijit Suttajit · 2009 · Chiang Mai Medical Journal - เชียงใหม่เวชสาร
56. Disparities in antidepressant adherence in primary care: report from Israel.
    Liat Ayalon, Revital Gross, Aviv Yaari, Elan Feldhamer, Ran D. Balicer, Margalit Goldfracht · 2011 · PubMed
57. Evaluación económica de la desvenlafaxina en el tratamiento de la depresión mayor en España
    Javier Rejas Gutiérrez, Milagrosa Blanca Tamayo, Josep Gascón Barrachina, Beatriz Armada Peláez · 2015 · Revista de Psiquiatría y Salud Mental
58. Méthodologie des essais thérapeutiques
    Florian Naudet, Bruno Falissard · 2014 · Time to knit
59. The Development and Psychometric Validation of the Fainareti Screening Tool for Perinatal Mental Health in Greek Pregnant Women
    Maria Dagla, Irina Mrvoljak-Theodoropoulou, Vassilis Daglas, Evangelia Antoniou, Eleni Rigoutsou, Alexandros Papatrechas, Calliope Dagla, Eleni P Tsolaridou, Despoina Karagianni · 2025 · Clinics and Practice
60. New insights into the molecular pathophysiology and treatment of depression
    Bornika Chattaraj, Sachin Karmakar, Rajiv Jash · 2025 · Neuroscience
61. Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (II) : Antidepressant Efficacy Compared with Placebo, Difference in Efficacy of Antidepressants, and Appropriate Time of Efficacy Judgment in Antidepressant Therapy
    Seung-Hwan Sung, Seon-Cheol Park, K. Han, Eunsoo Won, Hwa-Young Lee, J. Koo, J. Paik, Kyung-Min Lee, H. Jeon, Moon-Soo Lee et al. · 2013 · 신경정신의학
62. Improving Effect of Atomoxetine and Reboxetine on Memory in Passive Avoidance Task
    Murat Yuce, Fatih İlkaya, Koray Karabekiroğlu, Gökçe Nur Say, Mahmut Müjdeci, Filiz Bayril, Arzu Erdal Ağrı, Hasan Güzel, Faruk Aydin · 2014 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
63. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2009 · Springer eBooks
64. Evaluation and treatment of male pelvic pain syndromes and sexual dysfunction
    Darius A. Paduch · 2008 · Current Prostate Reports
65. Effectiveness and tolerability of eight-week treatment with dosulepin hydrochloride in patients with major depressive disorder not responding to four consecutive weeks of treatment with single selective serotonin reuptake inhibitor
    M. Suresh Kumar, Amrit Pattojoshi · 2021 · International Journal of Advances in Medicine
66. The epidemiology, burden, and treatment of mental disorders in primary care
    Bernd Puschner, Markus Kösters, Lea Bouché, Stefan Weinmann · 2017 · Oxford University Press eBooks
67. Therapy in clinical practice
    Jeffrey A. Cohen, Richard A. Rudick · 2011 · Cambridge University Press eBooks
68. A comparative study on efficacy of amitriptyline and escitalopram in the treatment of depression
    Sushant Aryal, Kajal Chakrabarti, Mayuri Gupta · 2018 · International Journal of Basic & Clinical Pharmacology
69. The Efficacy of Cognitive Behavioral Therapy in Addition to Pharmacotherapy Versus Pharmacotherapy Alone in the Treatment of Major Depressive Disorder in the Pakistani Population
    Ali Bux Rajper, Jawed Akbar Dars, Fariha Iqbal, Ghulam Rasool, Chooni Lal, Muzamil Hyder, Muhammad Iqbal Afridi, Fareed Aslam Minhas, Kiran Abbas · 2022 · Pakistan Journal of Medical and Health Sciences
70. Médiations thérapeutiques et apaisement des symptômes psychiatriques, une enquête rétrospective
    Catherine Monfort, Jean-Claude Monfort, Alain Mallet, Martine Colignon, Gersende Pradels, Jean‐Luc Sudres · 2025 · Soins Psychiatrie
71. The emerging field of cognitive brain–computer interfaces
    Ignacio Sáez · 2026 · Trends in Cognitive Sciences
72. Vagus nerve stimulation for treatment-resistant depression: protocol for a pilot self-controlled trial
    Gang Wang, Jingjing Zhou, Jian Yang, Xiao-hua Zhang · 2018 · Asia Pacific Journal of Clinical Trials Nervous System Diseases
73. Antidepressiva in de dagelijkse praktijk
    L. D. de Wit, A. Beekman, O. Maarsingh, H. van der Horst, C. Vinkers · 2019 · Huisarts en Wetenschap
74. Antidepressiva zur Behandlung der Depression bei Palliativpatienten: Eine systematische Literaturübersicht
    Mariam Ujeyl, Bruno Müller-Oerlinghausen · 2012 · Der Schmerz
75. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2012 · Springer eBooks
76. Tricyclics: Imipramine, Clomipramine, Trimipramine (Dibenzazepines)
    Hans‐Peter Volz, Gerd Laux · 2022 · Springer eBooks
77. Inference and Non-regularity
    Bibhas Chakraborty, Erica E. M. Moodie · 2013 · Statistics in the health sciences
78. A Primary Care Perspective on Prescribing for Women
    Dee A. Mangin · 2014 · Springer eBooks
79. Different Effects of Fluoxetine and Paroxetine Combined with Vitamin D3 in Ovariectomized Rats Exposed to Unpredictable Stress
    Julia Fedotova · 2020 · The Open Biology Journal
80. Depressive disorders
    Andrea M. Fagiolini, Giovanni Amodeo, Giuseppe Maina · 2017
81. Structure-activity relationship of methylene blue and its analogues as lead compounds for novel antidepressant development
    Ingrid Duvenhage · 2010 · Boloka Institutional Repository (North-west University)
82. Improving long-term outcome of major depression in primary care: the role of recurrence prevention
    Annet Smit · 2007 · International Journal of Integrated Care
83. THE EFFECTS OF ELECTROCONVULSIVE THERAPY OR REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON OLFACTORY SENSITIVITY AND IDENTIFICATION IN INDIVIDUALS WITH DEPRESSION
    Elaine Choi · 2015 · QSpace (Queen's University Library)
84. Correction: Dense Cranial Electroacupuncture Stimulation for Major Depressive Disorder—A Single-Blind, Randomized, Controlled Study
    Zhang‐Jin Zhang, Roger Ng, Sui Cheung Man, Tsui Yin Jade Li, Wendy Wong, Qing-Rong Tan, Hei Kiu Wong, Ka‐Fai Chung, Man-Tak Wong, Wai-Kiu Alfert Tsang et al. · 2012 · PLoS ONE
85. Cognitive-Behavioural Therapy Combined with Antidepressants for Major Depressive Disorder
    Narong Maneeton · 2012 · InTech eBooks
86. Unipolare Depression–Pharmakitherapie und Psychotherapie (ICD-10 F3)
    Max Schmauß, Elisabeth Schramm, Thomas Berger · 2008 · Elsevier eBooks
87. Solving the problem of antidepressant selection in Lithuania.
    Benjaminas Burba, O. Jankuviene, Viktorija Grigaliunien, Agnė Stolygaitė, Algirdas Jaras · 2007 · PubMed
88. Somatic symptoms in relation to severity of depression, quality of life and life satisfaction after antidepressive drug therapy in inpatients treated with a major depressive episode
    Effrosyni Kokkoli · 2013 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
89. Lichamelijke inspanning als (adjuvante) therapie bij depressie en angststoornissen
    Fred Hartgens, Koen R.J. Schruers, Eric J.L. Griez · 2008 · Stimulus
90. Las dificultades para un diagnóstico preciso de la depresión y sus consecuencias en la práctica asistencial
    Ramon Ciurana Misol · 2007 · FMC - Formación Médica Continuada en Atención Primaria
91. Is There A Role For “Older” Agents in Child Psychopharmacology?
    NORMAND J. CARREY · 2009 · Child and Adolescent Psychopharmacology News
92. In This Issue: Subtle Clinical Policy
    Kurt C. Stange · 2005 · The Annals of Family Medicine
93. Psychologist researcher-clinicians: The general medical setting beckons!
    Herbert C. Schulberg · 2006 · Clinical Psychology Science and Practice
94. Correlation study of SSRIs drugs in Sexual Dysfunction
    Masood Moghadamnia, Seyed Masood Nabavi, Siamak Afshin‐Majd · 2013
95. Depression in multiple sclerosis
    Adam Ian Kaplin, Ryan E. Stagg · 2011 · Cambridge University Press eBooks
96. Behandlung depressiver Störungen
    Max Schmauß, Thomas Messer · 2015 · Springer eBooks
97. ИСПОЛЬЗОВАНИЕ АНТИДЕПРЕССАНТОВ ПЕРВОГО РЯДА В КОМПЛЕКСНОЙ ТЕРАПИИ БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
    Aleksandr A. Evsyukov, Natalia P. Garganeeva, Марина Михайловна Петрова, Darya Sergeevna Kaskaeva · 2011 · CyberLeninK (CyberLeninka)
98. Glutamate of Hippocampus Involved in Remission of Depression by Acupuncture in Rats
    Ling Fan, Zhao Chen, Wenbin Fu, Nenggui Xu, Jianhua Liu, LV Ai-ping, Ziping Li, Shengyong Su, Taixiang Wu, Aihua Ou · 2016 · Medical Acupuncture
99. Depression Management in the Medical Home
    Justin M. Nash, Marisa Sklar, Daniel R. Evans · 2015 · Springer eBooks
100. Office management of depression
     Sarah M. Appleton · 2016 · Cambridge University Press eBooks